Literature DB >> 11006217

Elevated levels of proteolytic enzymes in the aging human vitreous.

A Vaughan-Thomas1, S J Gilbert, V C Duance.   

Abstract

PURPOSE: To identify whether aging of human vitreous is accompanied by an elevation in degradative enzymes within the tissue.
METHODS: Human vitreous samples from donors aged 10 to 88 years were placed in two groups based on donor age of less than or more than 50 years. Homogenized samples were analyzed by gelatin substrate zymography for matrix metalloproteinases (MMP). Serine proteinases were detected by casein substrate zymography, and a specific antibody was used to confirm the identity of, and to quantify, the serine proteinase, plasmin.
RESULTS: Progelatinase A (ProMMP-2) was present in all the vitreous samples but did not show an age-related increase. MMP-2 was also present at low levels. Progelatinase B (ProMMP-9) was found in approximately 80% of samples analyzed, but neither its presence nor level of activity was age dependent. Of the serine proteinase activities detected, an enzyme of approximately 80 kDa was identified by Western blot analysis as plasmin(ogen). Quantitative analysis revealed a significant increase in plasmin(ogen) with age.
CONCLUSIONS: This study shows there is an age-related increase in potential degradative activity in human vitreous that may be responsible for degenerative changes such as vitreous liquefaction. The data suggest that increased levels of these enzymes precede, or are indicative of, underlying ocular disease in some individuals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11006217

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

Review 1.  In Vivo Stability of Therapeutic Proteins.

Authors:  Joachim Schuster; Atanas Koulov; Hanns-Christian Mahler; Pascal Detampel; Joerg Huwyler; Satish Singh; Roman Mathaes
Journal:  Pharm Res       Date:  2020-01-03       Impact factor: 4.200

2.  Regulation of pathologic retinal angiogenesis in mice and inhibition of VEGF-VEGFR2 binding by soluble heparan sulfate.

Authors:  Koji M Nishiguchi; Keiko Kataoka; Shu Kachi; Keiichi Komeima; Hiroko Terasaki
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

3.  Effect of intravitreal plasmin on vitreous removal through a 25-gauge cutting system in the rabbit in vivo.

Authors:  Martin Hermel; Jonathan Prenner; Motaz Alabdulrazzak; Wendy Dailey; Michael Hartzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

Review 4.  Peptidomimetics Therapeutics for Retinal Disease.

Authors:  Dylan E Parsons; Soo Hyeon Lee; Young Joo Sun; Gabriel Velez; Alexander G Bassuk; Mark Smith; Vinit B Mahajan
Journal:  Biomolecules       Date:  2021-02-24

5.  Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review.

Authors:  Eric W Schneider; Mark W Johnson
Journal:  Clin Ophthalmol       Date:  2011-08-18

6.  Exogenous sphingomyelinase increases collagen and sulphated glycosaminoglycan production by primary articular chondrocytes: an in vitro study.

Authors:  Sophie J Gilbert; Emma J Blain; Pamela Jones; Victor C Duance; Deborah J Mason
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

7.  Does protein kinase R mediate TNF-alpha- and ceramide-induced increases in expression and activation of matrix metalloproteinases in articular cartilage by a novel mechanism?

Authors:  Sophie J Gilbert; Victor C Duance; Deborah J Mason
Journal:  Arthritis Res Ther       Date:  2003-11-12       Impact factor: 5.156

Review 8.  Prospective Application of Activity-Based Proteomic Profiling in Vision Research-Potential Unique Insights into Ocular Protease Biology and Pathology.

Authors:  Hui Peng; John D Hulleman
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

9.  Therapeutic effect of bone marrow mesenchymal stem cells on laser-induced retinal injury in mice.

Authors:  Yuanfeng Jiang; Yan Zhang; Lingjun Zhang; Meiyan Wang; Xiaomin Zhang; Xiaorong Li
Journal:  Int J Mol Sci       Date:  2014-05-27       Impact factor: 5.923

10.  Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases.

Authors:  Hiroshi Yamada; Masahiko Yoneda; Masahiko Gosho; Tomohiro Kato; Masahiro Zako
Journal:  BMC Ophthalmol       Date:  2016-03-08       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.